A specialist in medical oncology, Dr. Kwiatkowski is renowned for his discovery of the TSC1 gene that led to new treatments for tumors that occur in patients with tuberous sclerosis complex (TSC). His lab continues to research mutations in TSC1 and TSC2 that can predict response to treatment for a variety of common cancers with mTOR inhibitors. He has written over 380 peer-reviewed publications and has received funding from the National Institutes of Health and the National Institute for Neurologic Disease and Stroke (NINDS). Among Dr. Kwiatkowski’s many awards are the LAM Foundation’s Scientific Advancement Award, the NINDS Javits Neuroscience Investigator Award and the Tuberous Sclerosis Alliance’s Manuel R. Gomez Award.